Skip to content
Study details
Enrolling now

Barrigel® PPRT Trial

Palette Life Sciences, Inc.
NCT IDNCT06496256ClinicalTrials.gov data as of Apr 2026
Target enrollment

84

Study length

about 3.2 years

Ages

18+

Sex

Male only

Locations

4 sites in MA, NJ, TX

What this study is about

This trial is testing if Barrigel can help protect the rectum from radiation damage during prostate cancer treatment. It involves using Barrigel to position the rectal wall away from the prostate, potentially reducing the amount of radiation delivered to the rectum.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Barrigel
  • 2.Use Transrectal Ultrasound

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Expanded Prostate Cancer Index Composite (EPIC) Urinary QOL, Expanded Prostate Cancer Index Composite (EPIC) bowel QOL

Body systems

Oncology